drugset / Trial / NCT00739453
A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Multicenter, open-label, phase 1, cohort dose escalation study to determine the Maximum Tolerated Dose (MTD) of OSI-906 in combination with erlotinib
Timeline
- Start
- 2008-10-23
- Primary completion
- 2012-03-03
- Completion
- 2012-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | linsitinib | Small molecule | — | Oral |
| Background | Erlotinib | Small molecule | — | Oral |